Skip to main content
. 2015 Sep 23;10(5):1925–1930. doi: 10.3892/etm.2015.2772

Table I.

Clinical data of study participants.

CKD group without hemodialysis Hemodialysis CKD group


Variable CKD3 CKD4 CKD5 1 2 group
Case number 11 12 14 39 62 16
Gender (m/f) 6/5 6/6 8/6 21/18 33/29 9/7
Age (years) 39.8±4.9 48.0±4.9 38.8±17.5 47.5±23.8 53.5±21.9 37.6±10.5
BMI 25.1±3.7 23.3±4.7 23.5±3.4 23.2±3.7 23.0±4.3 22.0±3.1
Dialysis time
(months) 40.1±15.9 39.8±15.7
Hb (g/l) 128±22 107±14 92.7±19.4 87.5±17.6 104±7 123±20
HCT 0.36±0.02 0.28±0.05 0.26±0.08 0.21±0.09 0.30±0.02 0.42±0.03
Alb (g/l) 37.5±4.3a 35.0±5.2a 33.9±5.3a 30.4±8.2a 31.0±4.4a 47.9±4.2
TC (mmol/l) 4.59±1.02a 4.88±1.10a 5.04±1.19 5.28±1.37a 5.37±1.36 4.27±1.41
TG (mmol/l) 2.29±1.79a 1.91±0.73a 1.73±0.94a 2.83±0.71a 2.96±0.81a 1.34±0.51
HDL (mmol/l) 1.23±0.41a 1.09±0.34a 0.99±0.15a 0.75±0.09a 0.80±0.02a 1.42±0.63
LDL (mmol/l) 2.57±0.74a 2.39±0.87a 2.34±0.81a 2.57±0.64a 2.53±0.68a 2.34±0.46
SCr (µmol/l) 231±69a 564±96a 1280±311a 793±296a 776±258a 60.8±10.6
CRP (mg/l) 4.28±4.84a 5.30±4.24a 7.06±4.31a 4.94±2.73ab 5.23±3.19ab 1.89±0.47
IL-6 (ng/ml) 2.05±1.03a 2.21±1.37a 3.17±1.05a 5.61±5.13ab 5.42±5.53ab 1.57±0.91
EPO (IU) 1.58±0.22 1.76±0.68 1.83±1.12 1.91±1.37 1.97±1.23 1.45±1.02
Resistin (ng/ml) 9.48±4.11a 14.1±6.7a 19.3±7.1a 23.1±4.2ab 22.6±5.6ab 8.72±2.32
a

P<0.01 compared with the control group

b

P<0.01 compared with the group without dialysis. Data are presented as the mean ± standard deviation. CKD, chronic kidney disease; BMI, body mass index; Hb, hemaglobin; HCT, hematocrit; Alb, albumin; TC, total cholesterol; TG, triglycerides; HDL, high density lipoprotein; LDL, low density lipoprotein; SCr, serum creatinine; CRP, C-reactive protein; IL, interleukin; EPO, erythropoietin.